Chotosan and cerebrovascular disorders: Clinical and experimental studies

Pharmacology, Toxicology and Pharmaceutical Science

• Clinical Study 100%
• Cerebrovascular Disease 100%
• Uncaria 100%
• Neuroprotective Agent 66%
• Kampo Medicine (Drug) 33%
• Brain Infarction 33%
• Hydroxyl Radical 33%
• Drug Action 33%
• Randomized Controlled Trial 33%
• Stroke Prone Spontaneously Hypertensive Rat 33%
• Multiinfarct Dementia 33%
• Glutamic Acid 33%
• Ischemia 33%
• Superoxide 33%
• Catalase 33%
• Gerbil 33%
• Medicinal Plant 33%

Keyphrases

• Cerebrovascular Disease 100%
• Chotosan 100%
• Uncaria Sinensis 42%
• Protective Effect 28%
• Neuroprotective Effect 28%
• Relaxation Effect 28%
• Endothelial Function 28%
• Kampo Formula 14%
• Medicinal Plants 14%
• Blood Pressure 14%
• Vascular Dementia 14%
• Brain Ischemia 14%
• Endothelium-dependent Relaxation 14%
• Hemorheology 14%
• Pharmacological Activities 14%
• Glutamate 14%
• SHRSP 14%
• Nitric Oxide Scavenging 14%
• Neuronal Death 14%
• Cultured Neurons 14%
• Hydroxyl Radical Scavenging Activity 14%
• Double-blind Randomized Controlled Trial 14%
• NO Donors 14%
• Catalase Activity 14%
• Delayed Neuronal Death 14%
• Asymptomatic Cerebral Infarction 14%
• Phenolic Fraction 14%
• Gerbil 14%
• Endothelium-independent 14%
• Alkaloidal Fraction 14%

Neuroscience

• Cerebrovascular Disease 100%
• Neuroprotective Agent 66%
• Neuronal Cell Death 66%
• Vascular Dementia 33%
• Glutamic Acid 33%
• Cerebral Infarction 33%
• Catalase 33%
• Randomized Controlled Trial 33%
• Kampo Medicine (Drug) 33%
• Ischemia 33%
• Cerebrovascular Accident 33%